MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting  mRNA by unknown
Jin et al. BMC Molecular Biol  (2016) 17:17 
DOI 10.1186/s12867-016-0070-z
RESEARCH ARTICLE
MicroRNA 433 regulates 
nonsense-mediated mRNA decay  
by targeting SMG5 mRNA
Yi Jin1,2†, Fang Zhang1†, Zhenfa Ma1 and Zhuqing Ren1,2*
Abstract 
Background: Nonsense-mediated mRNA decay (NMD) is a RNA quality surveillance system for eukaryotes. It pre-
vents cells from generating deleterious truncated proteins by degrading abnormal mRNAs that harbor premature 
termination codon (PTC). However, little is known about the molecular regulation mechanism underlying the inhibi-
tion of NMD by microRNAs.
Results: The present study demonstrated that miR-433 was involved in NMD pathway via negatively regulating 
SMG5. We provided evidence that (1) overexpression of miR-433 significantly suppressed the expression of SMG5 
(P < 0.05); (2) Both mRNA and protein expression levels of TBL2 and GADD45B, substrates of NMD, were increased 
when SMG5 was suppressed by siRNA; (3) Expression of SMG5, TBL2 and GADD45B were significantly increased by miR-
433 inhibitor (P < 0.05). These results together illustrated that miR-433 regulated NMD by targeting SMG5 mRNA.
Conclusions: Our study highlights that miR-433 represses nonsense mediated mRNA decay. The miR-433 targets 
3’-UTR of SMG5 and represses the expression of SMG5, whereas NMD activity is decreased when SMG5 is decreased. 
This discovery provides evidence for microRNA/NMD regulatory mechanism.
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Background
Nonsense-mediated mRNA decay (NMD) recognizes 
and degrades mRNAs that contain premature termina-
tion codon (PTC). This surveillance mechanism could 
prevent from generating deleterious truncated proteins 
[1, 2]. UPF1 is an essential factor for NMD, which can 
recognize abnormal translation termination, and activate 
NMD [3]. Previous studies have indicated that suppres-
sor with morphogenetic effect on genitalia 5 (SMG5) was 
involved in de-phosphorylation of UPF1 [4, 5]. SMG5 
and 7 shared a conserved 14-3-3 like domain that could 
recognize the phosphorylated UPF1 [6]. When UPF1 
was de-phosphorylated, SMG5 and 7 were recruited to 
the P-bodies [7]. Phosphorylated serine 1096 of UPF1 
could bind the heterodimer formed by SMG5–7 [8]. In 
addition this heterodimer cold increase affinity combin-
ing to UPF1 [9]. SMG5–7 and protein phosphatase 2A 
(PP2A) plays an important role in the recycling for UPF1 
[10, 11]. Furthermore, SMG5–7 interacts with deadeny-
lases CCR4-NOT complex [12], and SMG5 was associ-
ated to the decapping enhancer Prorich nuclear receptor 
co-activator 2 (PNRC2) recruiting the general decapping 
complex [13]. As the consequence, it is very important 
to investigate the expression and regulation of SMG5 
for further understanding of NMD. One recent study 
indicated that DEAD box protein Ddx5 regulated SMG5 
expression [14]. However, few studies have reported 
that microRNAs could regulate SMG5 expression. Here 
we demonstrated that a microRNA, miR-433, regulated 
SMG5 expression. Shih et al indicated that miR-433 was 
associated to poorer survival in ovarian cancer [15]. MiR-
433 expression was altered in gastric cancer [16], lung 
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dysplasia and myeloproliferative neoplasms [17, 18]. 
MiR-433 could also regulate the expression of SFRP2, 
GRB2, CREB1, and HDAC6, all of which were closely 
associated to cancer [19–23].
Two recent studies reported that miR-128, miR-125a, 
and miR-125b regulated NMD through silencing UPF1 
and SMG1 [24, 25]. In present study, we demonstrated 
that miR-433 repressed the expression of SMG5, thereby 
suppressed NMD activity. Additionally, there may be a 
miR-433/NMD regulatory circuit in eukaryotic cells.
Results
MiRNA‑433 targets 3′‑UTR of SMG5
We selected the possible miRNAs targeting SMG5 
through miRNA algorithm TargetScan (http://www.
targetscan.org/), miRanda (http://www.microrna.org/
microrna/home.do), RNAhydrid (http://www.bibiserv.
techfak.uni-bielefeld.de/rnahybrid/), and FINDTAR 
(http://www.bio.sz.tsinghua.edu.cn/). The prediction of 
all the softwares indicates that miR-433 targets SMG5 
(Fig.  1a). The 3′-UTR of SMG5 holds a sequence motif 
(AUCAUGA) that is identical to the seed sequence UAG-
UACU (UAGUACU) of miR-433 (Fig. 1a). We performed 
the dual-luciferase assay to investigate miR-433 targeting 
SMG5. The wild report gene vector pmirGLO-SMG5-
WT and miR-433 mimic were co-transfected into HEK-
293T cells. Then we detected the normalized luciferase 
values, which showed 50  % reduction compared with 
controls (P < 0.01, Fig. 1b). However, this regulation was 
abrogated when a four-nucleotide mutation (AUGA–
UACU) was introduced in the miR-433 seed sequence in 
the 3′-UTR of SMG5 (Fig. 1b). Additionally, the expres-
sion level of luciferase in SMG5 mutant was increased 
compared to SMG5 WT in the presence of NC (Fig. 1d). 
Furthermore, the dual-luciferase vectors and miR-433 
inhibitor were co-transfected into Hela cells. The result 
showed SMG5 expression was increased (Fig.  1c). This 
regulation was also abrogated when the pmirGLO-
SMG5-MUT was transfected (Fig.  1c). In general, the 
results together showed that miR-433 targets 3′-UTR of 
SMG5 directly.
The suppression of SMG5 repressed NMD activity
The previous studies have indicated that SMG5 was an 
important NMD factor, so we are going to suppresse 
SMG5 expression by RNAi to confirm this function. The 
siRNA was transfected into C2C12 cells for 24–48 h. The 
results showed that SMG5 was decreased in both mRNA 
and protein expression level (Fig. 2a, b). According to the 
NMD mechanism, if NMD activity reduced, the expres-
sion of NMD substrates would be reduced. The NMD 
activity thereby was indicated by the expression level of 
NMD substrates, TBL2 and GADD45B. We detected the 
expression level of TBL2 and GADD45 and found that 
both of them were increased (P < 0.05, Fig. 2c–f). There-
fore the RNAi experiment indicated that suppression of 
SMG5 repressed NMD activity.
MiR‑433 repressed SMG5 expression
When we transfected miR-433 mimic into BHK cells, 
the expression level of SMG5 was decreased, (P  <  0.01, 
Fig.  3). Furthermore, the expression level of SMG5 was 
increased significantly when the miR-433 inhibitor was 
transfected into the BHK cells (P  <  0.01, Fig.  3). As the 
consequence, the SMG5 expression was down-regulated 
by miR-433.
MiR‑433 repressed NMD activity
Since we have demonstrated that miR-433 repressed 
SMG5 expression and suppression of SMG5 repressed 
NMD activity, miR-433 would repress NMD activity. In 
Fig. 1 MiR-433 targets the 3′-UTR of SMG5. a The predicated seed 
sequence in 3’-UTR of SMG5 by targetscan (http://www.targetscan.
org/). b Luciferase expression level in HEK 293T cells transfected for 
24 h with miR-433 mimic or a negative-control microRNA mimic.  
c Luciferase expression in Hela cells transfected for 48 h with miR-433 
inhibitor or a negative-control inhibitor. d Luciferase expression level 
of the SMG5 WT vs SMG5 mutant in HEK 293T cells transfected for 
24 h with a negative-control microRNA mimic (NC). *P < 0.05, and ** 
means the difference is significant, P < 0.01
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this section, the results showed that the NMD substrates 
TBL2 and GADD45B were increased in BHK cells when 
transfected with miR-433 mimic (P < 0.05, Fig. 4). In addi-
tion, we chose another cell line (C2C12) to transfect miR-
433 inhibitor. The expression level of TBL2 and GADD45B 
were also decreased by miR-433 inhibitor (P < 0.05, Fig. 4).
Discussion
Nonsense-mediated mRNA decay, a surveillance system, 
which recognizes mRNAs with translation termination 
codons positioned in abnormal contexts and degrades 
aberrant mRNAs, scrutinizes mRNA quality in all mam-
malian cells [26]. In this intricate process, a set of NMD 
factors are influential to the recognition and degrada-
tion of aberrant mRNAs. UPF1, the master regulator 
of NMD, is considered to determine the NMD process 
[27–29]. The ATPase and helicase activities as well as the 
phosphorylation of N- and C- terminal domains bestow 
on UPF1 ability that recognizes premature termina-
tion codon containing mRNAs selectively [30–33]. The 
phosphorylation and de-phosphorylation of UPF1 were 
very important for NMD. SMG5, an important NMD 
factor, played an important role in UPF1 de-phospho-
rylation process. As our results showed, NMD activity 
was repressed when the expression of SMG5 was sup-
pressed. So the regulation for SMG5 could affect NMD 
activity. We selected a microRNA, miR-433, which tar-
gets 3′-UTR of SMG5 by prediction. The regulation of 
miR-433 targeted SMG5 was detected by dual-luciferase 
report assay. The result indicated that SMG5 expression 
was reduced by 50 % when we transfected with miR-433 
mimic. It has demonstrated that the NMD activity was 
repressed when SMG5 was suppressed (Fig.  3). Hence, 
miRNA-433 repressed NMD activity by suppressing 
SMG5 expression.
As a conserved mRNA surveillance system in eukary-
otic cells, NMD is crucial for many physiological pro-
cesses, and these crucial function of NMD have been 
published by many researches. Numbers of NMD fac-
tors were important for embryo development. When 
UPF1, UPF2, SMG1 or SMG6 was knockout or knock-
down technologically, all mice died during an early 
embryonic stage [34–37]. A study implied that NMD 
has the potency that affects cell type diversification [34]. 
NMD activity was identified to be reduced in neuronal 
stem cells differentiation process. And this regulation 
of NMD activity is essential for nervous system devel-
opment [38]. Additionally, NMD also regulates neural 
Fig. 2 Knockdown SMG5 expression repressed NMD activity. a Quan-
titative polymerase chain reaction (qPCR) analysis of SMG5 mRNA 
expression in C2C12 cells transfected for 24 h with either three RNA 
interference fragments or negative control, positive control and Mock 
respectively. b Western Blot analysis of endogenous SMG5 protein 
levels in C2C12 cells 24 h after transfection with the RNA interfer-
ence fragment or a negative control fragment. β-actin was used as 
the internal control. c–f showed the qPCR and western blot analysis 
of NMD substrates, TBL2 and GADD45B, mRNA and protein level in 
C2C12 cells 24 h after transfection with the RNA interference frag-
ment or a negative control fragment. β-actin was used as the internal 
control. *P < 0.05; **P < 0.01
Fig. 3 MiR-433 reduced SMG5 protein and mRNA level. a Western 
Blot analysis of endogenous SMG5 protein levels in BHK cells 48 h 
after transfection with mature miR-433 mimic or a random negative-
control miRNA mimic (in C2C12 cells 48 h after transfection with 
miR-433 inhibitor or a random negative-control). β-actin was used as 
the internal control. b Quantitative polymerase chain reaction (qPCR) 
analysis of BHK cells transfected for 48 h with the miR-433 mimic or 
inhibitors (in C2C12 cells). Shown are the results from three inde-
pendent experiments, normalized to β-actin mRNA levels. **P < 0.01
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development related genes [39, 40]. Here, our experi-
ment indicated that miR-433 repressed SMG5 expres-
sion, and therefore suppressed NMD activity. This 
result indicated a circuit regulation of miR-433 and 
NMD. Hence, miR-433 could participate in the process 
regulated by NMD. For the circuit regulation, previous 
study identified miR-128 repressed NMD by UPF1 and 
MLN51 [24]. MiR-125 and 128 were involved in many 
nervous system disorder diseases such as autism [41], 
prion-induced neuron degeneration [42], Huntington’s 
disease [43], Parkinson’s disease [44], as well as Alzhei-
mer’s disease [45]. Some studies indicated that NMD 
played an important role in brain development and 
embryonic development [46, 47], and three essential 
embryonic brain vesicles formation disrupted by knock-
out of SMG1 [48]. Therefore, we assumed that there 
may be a miR-433/NMD regulatory circuit in early 
embryo development, especially in early nervous and 
brain development. This study would provide evidence 
to make clear the microRNA/NMD regulatory mecha-
nism and give advice to neurological disease and related 
cancers therapies.
Conclusion
It is well known that nonsense mediated mRNA decay 
is an important mRNA quality surveillance system. 
However, the microRNA/NMD regulatory mechanism 
is not fully clear. Our study claim that NMD activity is 
repressed by a microRNA, miR-433. The miR-433 tar-
gets 3′UTR of SMG5 and decreases the expression of 
SMG5. NMD activity is suppressed when expression of 
SMG5 is reduced. This discovery provides evidence for 
microRNA/NMD regulatory mechanism and therapeutic 
advice for NMD-related diseases.
Methods
Cell culture
The cell lines, HEK-293T, Hela, BHK-21, and C2C12, 
were purchased from China for type culture collection 
(CCTCC). Cells expect for Hela were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM, Hyclone, 
Logan, Utah, USA) supplemented with 10 % fetal bovine 
serum (FBS, Hyclone, Logan, Utah, USA) at 37  °C in 
a humidified atmosphere of 5  % CO2. Hela cells were 
maintained in DMEM (Hyclone, Logan, Utah, USA) con-
taining 20 % FBS (Hyclone, Logan, Utah, USA) at 37  °C 
in a humidified atmosphere of 5  % CO2. Medium was 
changed twice weekly until the fibroblasts migrated out 
to cover the dishes. Passage 6–9 cells were used for all 
experiments.
Isolation of 3′‑UTR sequences of SMG5
C2C12 genome DNA was used as template to amplify 
3′-UTR of SMG5. To isolate the 464-bp 3′-UTR of 
2.6-kb genome, the following primer pairs were used: 
SMG5-3′UTR-F and SMG5-3′UTR-R [5′-cgagctcCTG 
TACTGGATAAGGGGTGCC-3′ and 5′-ccgctcgagCA 
ACTGTTCCCTGGTTTTCCC, with uppercase bases 
corresponding to the mouse 2.6-kb SMG5 genome and 
lowercase bases indicating 5′ extensions with restric-
tion enzyme sites (underline) for SacI and XhoI, respec-
tively]. The protocol was as follows: pre-denaturation at 
94 °C for 2 min, denaturation at 94 °C for 30 s, annealing 
at 64  °C for 30  s, elongation at 72  °C for 30  s per 1  kb, 
thirty-five cycles, elongation at 72 °C for 2 min, and end. 
Fig. 4 a, c Western Blot analysis of endogenous NMD substrates, 
TBL2 and GADD45B protein levels in cells 24 h after transfection with 
the miR-433 mimic (in BHK cells) or miR-433 inhibitor (in C2C12 
cells) or a negative control miRNA mimic. β-actin was used as the 
internal control. b, d QPCR analysis of two NMD substrates, TBL2 and 
GADD45B relative mRNA expression level in cells 24 h after transfec-
tion with the miR-433 mimic (in BHK cells) or miR-433 inhibitor (in 
C2C12 cells) or a negative control miRNA mimic. *P < 0.05; **P < 0.01
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PCR products were investigated by 1–2  % agarose gel 
electrophoresis. The restriction enzyme, SacI and XhoI 
were purchased from Fermentas (Thermo Fisher Scien-
tific, Rockford, IL, USA).
Wild type report gene constructs
The 2.2. PCR product was purified and cloned into the 
SacI and XhoI sites of pmirGLO dual-luciferase miRNA 
target expression vector (Promega, Madison, WI, USA). 
The enzyme digestion system contained 10× buffer 4 μL, 
SacI 4  μL, XhoI 4  μL, pmirGLO vector 12  μL, and the 
ddH2O up to 40  μL. The enzyme digestion system was 
incubated at 37 °C for 2 h. The T4 DNA ligase (TaKaRa) 
interaction system contained enzyme digestion frag-
ment 3  μL, digested pmirGLO plasmid 2  μL, Solution 
I 5  μL. The system was incubated at 16  °C for 2  h. The 
accuracy of inserted 3′-UTR of SMG5 were confirmed by 
sequencing. Then the plasmid was isolated and purified 
using E.Z.N.A. ® endo-free plasmid mini kit II (OMEGA, 
Bio-Tek, Norcross, GA, USA). The constructed wild type 
report gene recombinants named pmirGLO-SMG5-WT 
was stored at −20 °C.
Introducing four‑nucleotide mutagenesis into SMG5 
3′‑UTR
Two primer pairs, SMG5-3′UTR-F (5′-cgagctcCTGTA 
CTGGATAAGGGGTGCC-3′) and SMG5-3′UTR-R 
(5 ′-ccgctcgagCAACTGTTCCCTGGTTTTCCC), 
SMG5-3′UTR-MF (5′-AGCAGAGATCTACTATACTC 
AG-3′) and SMG5-3′UTR-MR (5′-GCCCCTGAGT 
ATAGTAGATCTCTG-3′), were designed (uppercase 
bases corresponding to the mouse 2.6-kb SMG5 genome 
and lowercase bases indicating 5′ extensions with restric-
tion enzyme sites [underline] for SacI and XhoI, respec-
tively. And the bold bases mean four-nucleotide mutation 
sites of SMG5 3′-UTR). The former was used to construct 
pmirGLO-SMG5-WT, whereas the latter to amplify the 
mutation sites and its upstream sequence (production 
I), and the mutation sites and its downstream sequence 
(production II) respectively, the pmirGLO-SMG5-WT 
plasmid was the template. Then using fusion PCR com-
bined these two products. The PCR system contained 
2×  taq PCR mix 11  μL, recovered production I 2  μL, 
recovered production II 2 μL, ddH2O 10 μL. PCR condi-
tions: an initial denaturation at 95 °C for 4 min, followed 
by 30 cycles of 95 °C for 30 s, 40 °C for 30 s, 45 °C for 5 s, 
50 °C for 5 s, 55 °C for 5 s, 60 °C for 5 s and 72 °C for 30 s, 
with a final extension of 5  min at 72  °C. PCR products 
were visible after electrophoresis of 25-μL reaction using 
an agarose gel (1.5 %). Then the fusion PCR production 
was recovered and used as a template.
Mutant report gene constructs
The 464  bp mutant SMG5 3′-UTR was amplified, puri-
fied, and cloned into the SacI and XhoI sites of pmirGLO 
dual-luciferase miRNA target expression vector (Pro-
mega, Madison, WI). The enzyme digestion system con-
tained 10× buffer 4 μL, SacI 4 μL, XhoI 4 μL, pmirGLO 
vector 12 μL, and ddH2O up to 40 μL. The enzyme diges-
tion system was incubated at 37 °C for 2 h. The T4 DNA 
ligase (TaKaRa) interaction system contained enzyme 
digestion fragment 3  μL, digested pmirGLO plasmid 
2 μL, Solution I 5 μL. This system was incubated at 16 °C 
for 2 h. The accuracy of inserted SMG5 3′-UTR was con-
firmed by sequencing. Then the plasmid was isolated 
and purified using E.Z.N.A. ® endo-free plasmid mini kit 
II (OMEGA, Bio-Tek, Norcross, GA, USA). The mutant 
report gene vector,named pmirGLO-SMG5-MUT con-
served at −20 °C.
Cell transfection and dual‑luciferase assay
HEK-293T cells were seeded onto 24-well plates at 
30–40 % confluence. The next day, medium was changed 
to Opti-MEM I Reduced Serum Medium (Hyclone, 
Logan, Utah, USA), and cells were transfected with 
pmirGLO-SMG5-WT constructs (200  ng per well). 
After 4–6  h, medium was replaced by MEM contain-
ing 10 % FBS (Hyclone, Logan, Utah, USA). Transfected 
cells were washed twice with cold PBS (Hyclone, Logan, 
Utah, USA), lysed using 1×  passive lysis buffer (Pro-
mega) for 30 min, and assayed for firefly and Renilla lucif-
erase activities by the dual-luciferase assay (Promega) 
in a PerkimELmer 2030 Microplate Reader (Lenovo, 
China) according to the manufacturer’s instructions. At 
least three independent experiments were performed 
for each assay, each time with a minimum of n = 4. For 
co-transfection, cells were grown on 24-well plates. For 
each well, a transfection mixture (200  μL) consisting of 
0.2-μg reporter construct, 1.25  μL miR-433 mimic or 
negative control, and 2  μL Lipofectamine 2000 Reagent 
(Invitrogen) was prepared. Opti-MEM I Reduced Serum 
Medium was used as diluent. Hella cells were treated as 
same as the HEK-293T, but the medium was MEM con-
taining 20 % FBS.
RNA isolation and mRNA/miRNA quantitation
The RNA isolation reagent was TRizol® Reagent (Invit-
rogen, Carlsbad, CA, USA). RNA was quantified spec-
troscopically (ND-1000 Spectrophotometer; NanoDrop, 
Wilmington, DE, USA), and integrity was assessed by 
agarose gel electrophoresis. According to the manufac-
turer’s protocol, RNA was reverse-transcribed using 
RNA PCR kit (Takara Bio Inc.). The gene expression was 
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investigated by RT-PCR. Primers for RT-PCR were as fol-
lows: SMG5-qF (5′-TACCTCATCCCTGACACCCA-3′) 
and SMG5-qR (5′-GCCCCTGGCTGTTCTTTCT-3′), 
miR-433-qF (CTGGTAGGATCATGATGGGAT) and 
miR-433-qR (TCAACTGGTGTCGTGGAGT), U6-qF 
(CTGGTAGGGTGCTCGCTTCGGCAG) and U6-qR 
(CAACTGGTGTCGTGGAGTCGGC), TBL2-qF (5′-AA 
GTATCTGGCCACCTGTGC-3′) and TBL2-qR (5′-GG 
CCAGCCAAACAATGAAGG-3′), GADD45B-qF (5′-AA 
GGCGGCCAAACTGATGAAT-3′) and GADD45B-qR 
(5′-ATTGTCGCAGCAGAACGACT-3′), β-actin-F (5′-G 
CCTCACTGTCCACCTTCCA-3′) and β-actin-R (5′-A 
GCCATGCCAATGTTGTCTCTT-3′). All the primer 
pairs for each gene were used for gene-specific amplifi-
cation. The expression of β-actin was the internal con-
trol. For quantification, the comparative threshold cycle 
method was used to assess relative changes in mRNA lev-
els [49].
MicroRNA overexpression assay
MiR-433 mimic and inhibitor were purchased from 
GenePharma (shanghai, China). MiR-433 mimic could 
enhance endogenous miR-433 function, and miR-433 
inhibitor could repress the endogenous miR-433 func-
tion. HK-21 cells and C2C12 cells were seeded onto 
6-well plates in DMEM supplemented with 10 % FBS at 
37  °C in a humidified atmosphere of 5 % CO2. The next 
day, when the cells confluence get 70–80 %, the medium 
was changed to Opti-MEM I Reduced Serum Medium 
(Hyclone, Logan, Utah, USA), and cells were trans-
fected with 10  μL miRNA mimic (0.02  nmol/μL) using 
Lipofectamine 2000 Reagent (Invitrogen). After 4–6  h, 
medium was replaced by MEM containing 10  % FBS 
(Hyclone, Logan, Utah, USA). Transfected cells were 
washed twice with cold PBS (Hyclone, Logan, Utah, 
USA). At least three independent experiments were 
performed for each assay, each time with a minimum of 
n =  4. Opti-MEM I Reduced Serum Medium was used 
as diluent. The mimic was added fluorescent tag so that it 
could be detected under fluorescence microscope to cal-
culate the transfection efficiency.
Small interfering RNA design and cell transfection
The musSMG5 mRNA sequence and internal control 
(β-actin) mRNA sequences were obtained from NCBI 
database (http://www.ncbi.nlm.nih.gov/). The siRNAs 
were purchased from Genpharma (Inc. Shanghai, 
China). The sequences if siRNAs were as follows: 
siRNA1 5′-GCCGCUUCAUCAUCAUCAUTT-3′ for 
sense and 5′-AUGAUGAUGAUGAAGCGGCTT-3′ for 
antisense; siRNA2 5′-GGAGUGUGAAAGUGGAUAU 
TT-3′ for sense and 5′-AUAUCCACUUUCACACU 
CCTT-3′ for antisense; siRNA3 5′-GCAGGCAGCAA 
GUAUUACATT-3′ for sense and 5′-UGUAAUACUU 
GCUGCCUGCTT-3′ for antisense; NC (negative con-
trol) 5′-UUCUCCGAACGUGUCACGUTT-3′ for sense 
and 5′-ACGUGACACGUUCGGAGAATT-3′ for anti-
sense. C2C12 cells were incubated in 5 % CO2 at 37  °C 
in DMEM (Hyclone, Logan, Utah, USA) supplemented 
with 10  % FBS (Hyclone, Logan, Utah, USA). One day 
before transfection, 105 cells were plated in 2 mL DMEM 
containing 10 % FBS per well of a 6-well plate. The next 
day, when the cells confluence get 50  %, the medium 
was changed to Opti-MEM I Reduced Serum Medium 
(Hyclone, Logan, Utah, USA), and cells were transfected 
with 10 μL siRNA using 10 μL Lipofectamine 2000 Rea-
gent (Invitrogen). After 4–6 h, medium was replaced by 
MEM containing 10 % FBS (Hyclone, Logan, Utah, USA). 
The cells were incubated for 24–48  h. Transfected cells 
were washed twice with cold PBS (Hyclone, Logan, Utah, 
USA). At least three independent experiments were per-
formed for each assay, each time with a minimum of 
n =  4. Opti-MEM I Reduced Serum Medium was used 
as diluent.
Western blotting
The whole-cell protein of BHK-21 and C2C12 were col-
lected using RIPA and PMSF, and conserved at −20  °C. 
The concentration of protein was detected using the 
bicinchoninic acid (BCA) method (Beyotime Biotech-
nology, Jiangsu, China). Subsequently, samples were 
separated by SDS–PAGE (10 %) and electroblotted onto 
polyvinylidene fluoride (PVDF) membrane (Millipore, 
USA). Membrane was blocked with 1×  TBST supple-
mented with 5  % skimmed milk powder (servicebio, 
Wuhan, China). Membranes were incubated with the 
primary antibody, anti-SMG5 (P-14) (goat. #SC50980, 
Santa Cruz Biotechnology, Inc.). For normalization of 
the results, membranes were reblotted for β-actin (anti-
β-actin, servicebio, Wuhan). Proteins were detected 
with secondary antibody (HRP-rabbit, anti-goat, 1:1000; 
boster, Wuhan, China). For the TBL2 and GADD45B 
western blotting analysis, the primary antibodies were 
anti-TBL2 (L-15) (goat. #SC-104692, Santa Cruz Biotech-
nology, Inc.), and anti-GADD45B (rabbit, #ab128920, 
abcam, Inc.). Bands on the X-ray films were quanti-
fied with WCIF ImageJ software for the densitometry 
analysis.
Statistical analysis
All data were displayed as the mean  ±  SD of three 
independent experiments, in which each assay was 
performed in triplicate. Statistically significant dif-
ferences between two groups were determined by 
Student’s t test. P  <  0.05 was considered statistically 
significant.
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